About Michael McKenna, MD

Born and raised in Southern California, I moved to Boston in 1984 for residency training in otolaryngology. I returned to California in 1988 for fellowship training in neurotology and skull base surgery at the House Ear Clinic (Otologic Medical Group). In 1989 I received an academic appointment in the Department of Otology and Laryngology at Harvard Medical School, and joined the full-time staff at the Massachusetts Eye and Ear Infirmary. During the last twenty years, my clinical practice has been strictly limited to otology, neurotology and skull base surgery. A high percentage of the practice is tertiary referral from the eastern United States including over two hundred patients a year with acoustic neuromas and other skull base tumors. This experience has resulted in numerous clinical publications and invited presentations. Expertise in these areas has been recognized both nationally and internationally.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Massachusetts Eye and Ear Infirmary
243 Charles Street
Boston, MA 02114 - 3002
617-573-3672
Fax: 617-573-3914

Pappas Center for Neuro Oncology
55 Fruit Street
Boston, MA 02114
617-724-8770

Medical Education

  • MD, University of Southern California School of Medicine
  • Residency, Massachusetts Eye & Ear

American Board Certifications

  • Otolaryngology, American Board of Otolaryngology
  • Otology & Neurotology, American Board of Otolaryngology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

The focus of my research has been on understanding the pathophysiology and pathogenesis of otosclerosis, a bone disease of the human otic capsule that is amongst the most common causes of hearing loss in the general population. I began this line of investigation as a medical student and have maintained a focus in this area for over twenty five years. Our contributions in elucidating the possible role of measles virus, genetic and molecular mechanisms in the development of otosclerosis can be considered to be amongst the most significant contributions in the area of otosclerosis research in the last fifty years. We have received peer-review funding from the NIH over the last fifteen years, and were recently successful with a competitive renewal application. We are realistically hopeful that the by-product of this research will in the near future in lead to better forms of treatment and prevention.

Publications